Ebola remains a significant threat, with a severe outbreak in the Democratic Republic of Congo (DRC) involving over 7,000 cases of the Bundibugyo Ebola virus since May, resulting in around 3,500 deaths. Nicole Lurie from the Coalition for Epidemic Preparedness Innovations (CEPI) describes it as one of the most alarming epidemics, second only to Covid-19. The outbreak’s rapid growth is exacerbated by violence and distrust of aid workers, hindering efforts like contact tracing and treatment. CEPI has redirected $100 million to develop vaccines, with trials underway for candidates from Oxford University and Moderna. However, vaccine distrust poses a challenge. Teresa Lambe, leading Oxford’s trials, highlights the difficulty of deploying vaccines in unstable regions. The situation underscores the need for a vaccine to control the epidemic, despite the challenges in the DRC.
QUESTION: How might the distrust of vaccines in the DRC impact global efforts to control future outbreaks?
The Organization Fighting Ebola Has Never Been More Worried
